“Chimeric Antigen Receptor T-Cell Therapy for Relapsed and Refractory Large B-Cell Lymphoma: A Canadian Perspective”. Canadian Hematology Today 1, no. 2 (July 1, 2022): 22–29. Accessed October 22, 2026. https://canadianhematologytoday.com/article/view/1-2-4-elsawy.